Top

Gepubliceerd in:

01-09-2008 | original article

The many faces of aggressive aortic pathology: Loeys-Dietz syndrome

Auteurs: J. J. J. Aalberts, M. P. van den Berg, J. E. H. Bergman, G. J. du Marchie Sarvaas, J. G. Post, H. van Unen, G. Pals, P. W. Boonstra, J. P. van Tintelen

Gepubliceerd in: Netherlands Heart Journal | Uitgave 9/2008

Abstract

Background: Loeys-Dietz syndrome (LDS) is a newly recognised disorder of connective tissue which shares overlapping features with Marfan syndrome (MFS) and the vascular type of Ehlers- Danlos syndrome, including aortic root dilatation and skin abnormalities. It is clinically classified into types 1 and 2. LDS type 1 can be recognised by craniofacial characteristics, e.g. hypertelorism, bifid uvula or cleft palate, whereas these are absent in LDS type 2. It is important to recognise LDS because its vascular pathology is aggressive. We describe nine LDS patients from four families, relate their features to published cases, and discuss important aspects of the diagnosis and management of LDS in order to make clinicians aware of this new syndrome.

Results: Characteristics found in the majority of these LDS patients were aortic root dilatation, cleft palate and/or a bifid/abnormal uvula.

Conclusion: Because aortic dissection and rupture in LDS tend to occur at a young age or at aortic root diameters not considered at risk in MFS, and because the vascular pathology can be seen throughout the entire arterial tree, patients should be carefully followed up and aggressive surgical treatment is mandatory. Clinicians must therefore be aware of LDS as a cause of aggressive aortic pathology and that its distinguishing features can sometimes be easily recognised. (Neth Heart J 2008;16:299-304.)

vorige artikel Rescue of arterial function by angiotensin-(1-7): towards improvement of endothelial function by drug-eluting stents

volgende artikel Regenerative cell therapy and pharmacotherapeutic intervention in heart failure

Nienaber CA, Eagle KA. Aortic dissection: New Frontiers in diagnosis and management Part I: From Etiology to Diagnostic Strategies. Circulation 2003;108:628-35.

Januzzi JL, Isselbacher EM, Fattori R, Cooper JV, Smith DE, Fang J, et al. Characterizing the young patient with aortic dissection: results from the International Registry of Aortic Dissection (IRAD). J Am Coll Cardiol 2004;43:665-9.

Loeys BL, Chen J, Neptune ER, Judge DP, Podowski M, Holm T, et al. A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. Nat Genet 2005;37:275-81.

Loeys BL, Schwarze U, Holm T, Callewaert BL, Thomas GH, Pannu H, et al. Aneurysm syndromes caused by mutations in the TGF-beta receptor. N Engl J Med 2006:355:788-98.

Williams JA, Loeys BL, Nwakanma LU, Dietz HC, Spevak PJ, Patel ND, et al. Early surgical experience with Loeys-Dietz: A new syndrome of aggressive thoracic aortic aneurysm disease. Ann Thorac Surg 2007;83:S757-63.

Mizuguchi T, Collod-Beroud G, Akiyama T, Abifadel M, Harada N, Morisaki T, et al. Heterozygous TGFBR2 mutations in Marfan syndrome. Nat Genet 2004;36:855-60.

De Paepe A, Devereux RB, Dietz HC, Hennekam RCM, Pyeritz RE. Revised diagnostic criteria for the Marfan syndrome. Am J Med Genet 1996;62:417-26.

Dean JCS. Marfan syndrome: clinical diagnosis and management. Eur J Hum Genet 2007;15:724-33.

Akutsu K, Morisaki H, Takeshita S, Sakamoto S, Tamori Y, Yoshimuta T, et al. Phenotypic heterogeneity of Marfan-like connective tissue disorders associated with mutations in the transforming growth factor-beta genes. Circ J 2007;71:1305-9.

10.

Annes JP, Munger JS, Rifkin DB. Making sense of latent TGFbeta activation. J Cell Sci 2003;116:217-24.

11.

Mizuguchi T, Matsumoto N. Recent progress in genetics of Marfan syndrome and Marfan-associated disorders. J Hum Genet 2007;52:1-12.

12.

Azhar M, Schultz JEJ, Grupp I, Dorn GW, Meneton P, Molin DGM, et al. Transforming growth beta in cardiovascular development and function. Cytokine Growth Factor Rev 2003;14:391-407.

13.

LeMaire SA, Pannu H, Tran-Fadulu V, Carter SA, Coselli JS, Milewicz DM. Severe aortic and arterial aneurysms associated with a TGFBR2 mutation. Nat Clin Pract Cardiovasc Med 2007;4:167- 71.

14.

Habashi JP, Judge DP, Holm TM, Cohn RD, Loeys BL, Cooper TK, et al. Losartan, an ATI antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science 2006;312:117-21.

15.

Oderich GS, Pannenton JM, Bower TC, Lindor NM, Cherry KJ, Noel AA, et al. The spectrum, management and clinical outcome of Ehlers-Danlos syndrome type IV: a 30-year experience. J Vasc Surg 2005;42:98-106.

Titel: The many faces of aggressive aortic pathology: Loeys-Dietz syndrome
Auteurs: J. J. J. Aalberts
M. P. van den Berg
J. E. H. Bergman
G. J. du Marchie Sarvaas
J. G. Post
H. van Unen
G. Pals
P. W. Boonstra
J. P. van Tintelen
Publicatiedatum: 01-09-2008
Uitgeverij: Bohn Stafleu van Loghum
Gepubliceerd in: Netherlands Heart Journal / Uitgave 9/2008
Print ISSN: 1568-5888
Elektronisch ISSN: 1876-6250
DOI: https://doi.org/10.1007/BF03086168

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Abstract

Log in om toegang te krijgen

Andere artikelen Uitgave 9/2008

Rescue of arterial function by angiotensin-(1-7): towards improvement of endothelial function by drug-eluting stents

Combination of imaging modalities in a coronary artery fistula

The difference between ballistocardiography and stem cells

Recurrent acute pulmonary oedema after aortic and mitral valve surgery due to trachea malacia and obstructive sleep apnoea syndrome

Regenerative cell therapy and pharmacotherapeutic intervention in heart failure